Infect Immun 1998,66(2):732–740.PubMed 18. Garmory HS, Leary SE, Griffin KF, Williamson ED, Brown KA, Titball RW: The use of live attenuated bacteria as a delivery system for heterologous antigens. J Drug Target 2003,11(8–10):471–479.PubMedCrossRef 19. Hohmann EL, Oletta CA, Miller SI: Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 1996,14(1):19–24.PubMedCrossRef 20. Tacket CO, Kelly SM, Schodel F, Losonsky G, Nataro JP, Edelman R, Levine MM, Curtiss R 3rd: Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector
strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect Immun 1997,65(8):3381–3385.PubMed 21. Chatfield SN, Strugnell RA, Dougan G: Live Salmonella as vaccines and carriers Gamma-secretase inhibitor of foreign VX-689 cost antigenic determinants. Vaccine 1989,7(6):495–498.PubMedCrossRef 22. Curtiss R 3rd, selleckchem Wanda SY, Gunn BM, Zhang X, Tinge SA, Ananthnarayan V, Mo H, Wang S, Kong W: Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo. Infect Immun
2009,77(3):1071–1082.PubMedCrossRef 23. Heithoff DM, Enioutina EY, Daynes RA, Sinsheimer RL, Low DA, Mahan MJ: Salmonella DNA adenine methylase mutants confer cross-protective immunity. Infect Immun 2001,69(11):6725–6730.PubMedCrossRef 24. Matsui H, Suzuki M, Isshiki Y, Kodama C, Eguchi M, Kikuchi Y, Motokawa PAK6 K, Takaya A, Tomoyasu T, Yamamoto T: Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella
enterica serovar typhimurium. Infect Immun 2003,71(1):30–39.PubMedCrossRef 25. McFarland WC, Stocker BA: Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microb Pathog 1987,3(2):129–141.PubMedCrossRef 26. Miller SI, Loomis WP, Alpuche-Aranda C, Behlau I, Hohmann E: The PhoP virulence regulon and live oral Salmonella vaccines. Vaccine 1993,11(2):122–125.PubMedCrossRef 27. Angelakopoulos H, Hohmann EL: Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 2000,68(4):2135–2141.PubMedCrossRef 28. Hindle Z, Chatfield SN, Phillimore J, Bentley M, Johnson J, Cosgrove CA, Ghaem-Maghami M, Sexton A, Khan M, Brennan FR, et al.: Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect Immun 2002,70(7):3457–3467.PubMedCrossRef 29. Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, et al.: Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 2002,20(1):142–152.
Related posts:
- Infect Immun 2002,70(8):4165–4176 PubMedCrossRef 3 Marches O, Co
- Infect Immun 2011,79(6):2154–2167 PubMedCentral
- : Complete genome sequence of Salmonella enterica serovar Typhimu
- Infect Immun 2009,77(6):2447–2454 CrossRefPubMed 26 Zarnowski R,
- PubMed 21 Di Bonaventura G, Pompilio A, Picciani C, Nicoletti M,